Method shows potential in diagnosing early kidney damage

04/19/2013 | ScienceDaily

In order to detect early signs of kidney damage, researchers attached a fluorescent label on a human monoclonal antibody that targets a damaged collagen that can indicate kidney disease. The tagging method was effective in mice and in tissue taken from diseased human kidneys, according to a study published in Kidney International. For humans, the labeled antibodies need to be used with an advanced imaging method such as PET to allow for comprehensive evaluation of both kidneys, a researcher said. The antibody also shows potential for targeted delivery of drugs such as prostaglandin E2, which was shown in an American Journal of Physiology-Renal Physiology study to be effective in restoring kidney function of mice.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA